Exelixis
EXEL
#1563
Rank
A$19.84 B
Marketcap
A$80.10
Share price
-0.21%
Change (1 day)
36.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company